Skip to main content
. 2017 Aug 10;12(8):e0183023. doi: 10.1371/journal.pone.0183023

Fig 1. Optimised protocols for PD-L1 IHC assays using the 22C3 antibody concentrate on the Dako ASL48 and VENTANA BenchMark ULTRA platforms.

Fig 1

PD-L1, programmed death ligand 1; IHC, immunohistochemistry; ASL48, Autostainer Link 48; DAB, 3,3’-diaminobenzidine tetrahydrochloride.